Mini-Monograph Archive
Rat Uterotrophic Bioassay
111:1527-1570 (2003)
- The OECD Program to Validate the Rat Uterotrophic Bioassay: An Overview
- The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Dose-Response Studies
- The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Coded Single-Dose Studies
- The OECD Program to Validate the Rat Uterotrophic Bioassay. Phase 2: Dietary Phytoestrogen Analyses
- The Intact Immature Rodent Uterotrophic Bioassay: Possible Effects on Assay Sensitivity of Vomeronasal Signals from Male Rodents and Strain Differences
Regulatory Acceptance of (Q)SARs 111:1358-1401 (2003)
- Summary of a Workshop on Regulatory Acceptance of (Q)SARs for Human Health and Environmental Endpoints
- Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs
- Use of QSARs in International Decision-Making Frameworks to Predict Ecologic Effects and Environmental Fate of Chemical Substances
- Use of QSARs in International Decision-Making Frameworks to Predict Health Effects of Chemical Substances
Genetically Modified Foods
111:1110-1141 (2003)
- Introduction: What Are the Issues in Addressing the Allergenic Potential of Genetically Modified Foods?
- Clinical and Laboratory Investigation of Allergy to Genetically Modified Foods
- Protein Digestibility and Relevance to Allergenicity
- Assessment of Protein Allergenicity on the Basis of Immune Reactivity: Animal Models
- Key Issues for the Assessment of the Allergenic Potential of Genetically Modified Foods: Breakout Group Reports
- Assessment of Allergenic Potential of Genetically Modified Foods: An Agenda for Future Research
World Trade Center
111:971-991 (2003)
- World Trade Center Fine Particulate Matter--Chemistry and Toxic Respiratory Effects: An Overview
- Chemical Analysis of World Trade Center Fine Particulate Matter for Use in Toxicologic Assessment
- World Trade Center Fine Particulate Matter Causes Respiratory Tract Hyperresponsiveness in Mice
Green Pharmacy
111:757-785 (2003)
- Cradle-to-Cradle Stewardship of Drugs for Minimizing Their Environmental Disposition While Promoting Human Health. I. Rationale for and Avenues toward a Green Pharmacy
- Cradle-to-Cradle Stewardship of Drugs for Minimizing Their Environmental Disposition While Promoting Human Health. II. Drug Disposal, Waste Reduction, and Future Directions
Allergenicity Models
111:221-254 (2003)
- Animal Models to Detect Allergenicity to Foods and Genetically Modified Products: Workshop Summary
- Food Allergy: An Overview
- Assessment of the Inherent Allergenic Potential of Proteins in Mice
- Assessment of the Allergic Potential of Food Protein Extracts and Proteins on Oral Application Using the Brown Norway Rat Model
- Nonmurine Animal Models of Food Allergy
- Identification of Antigenic Epitopes on Human Allergens: Studies with HLA Transgenic Mice
- A Human Dendritic Cell-Based Method to Identify CD4+ T-Cell Epitopes in Potential Protein Allergens
Chemical Contaminants in Breast Milk: Impacts on Children's Health
110:A313-A351 (2002)
- Chemical Contaminants in Breast Milk and Their Impacts on Children's Health: An Overview
- Analytic Considerations for Measuring Environmental Chemicals in Breast Milk
- Infant Exposure to Dioxin-like Compounds in Breast Milk
- Pharmacokinetics of Toxic Chemicals in Breast Milk: Use of PBPK Models to Predict Infant Exposure
- Chemical Contaminants in Breast Milk: Time Trends and Regional Variability
- Global Perspectives in Breast Milk Contamination: Infectious and Toxic Hazards
Printable Version of This Page